UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
40 hedge funds and large institutions have $11.4M invested in Unity Biotechnology in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
8% more funds holding
Funds holding: 37 → 40 (+3)
0.85% less ownership
Funds ownership: 18.87% → 18.01% (-0.85%)
Holders
40
Holding in Top 10
3
Calls
$480K
Puts
$275K
Top Buyers
| 1 | +$8.46M | |
| 2 | +$85.6K | |
| 3 | +$45.8K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$32K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$29.8K |
Top Sellers
| 1 | -$590K | |
| 2 | -$38.2K | |
| 3 | -$20.7K | |
| 4 |
Squarepoint
New York
|
-$17.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$738 |
